Evidence map›Paper›PMID 35148778›Full record

ArticleBMC women's health2022

Developing a framework to describe stigma related to cervical cancer and HPV in western Kenya.

Ramya Ginjupalli, Rachel Mundaden, Yujung Choi, Emily Herfel, Sandra Yvonne Oketch, Melissa H Watt, Breandan Makhulo, Elizabeth Anne Bukusi, Megan Huchko

Abstract read
In one paragraph

Article in BMC women's health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ramya Ginjupalli *Center for Global Reproductive Health, Duke Global Health Institute, 310 Trent Dr, Durham, NC, 27710, USA. ramyacginjupalli@gmail.com.
Rachel Mundaden *Center for Global Reproductive Health, Duke Global Health Institute, 310 Trent Dr, Durham, NC, 27710, USA.
Yujung ChoiCenter for Global Reproductive Health, Duke Global Health Institute, 310 Trent Dr, Durham, NC, 27710, USA.
Emily HerfelCenter for Global Reproductive Health, Duke Global Health Institute, 310 Trent Dr, Durham, NC, 27710, USA.
Sandra Yvonne OketchCenter for Microbiology Research, Kenya Medical Research Institute, Off Mbagathi Road, P.O. Box 54840 00200, Nairobi, Kenya.
Melissa H WattDepartment of Population Health Sciences, University of Utah, Williams Building, Room 1N490, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.
Breandan MakhuloCenter for Microbiology Research, Kenya Medical Research Institute, Off Mbagathi Road, P.O. Box 54840 00200, Nairobi, Kenya.
Elizabeth Anne BukusiCenter for Microbiology Research, Kenya Medical Research Institute, Off Mbagathi Road, P.O. Box 54840 00200, Nairobi, Kenya.
Megan HuchkoCenter for Global Reproductive Health, Duke Global Health Institute, 310 Trent Dr, Durham, NC, 27710, USA.

Funding

Developing a tool to measure cervical cancer stigma among HIV+ women in KenyaR21TW011061 · FIC · DUKE UNIVERSITY · PI HUCHKO, MEGAN J. · 2019 to 2020
$363k
FIC NIH HHS R21 TW011061
6 · The paper itself

Abstract

backgroundDespite a high prevalence of human papillomavirus (HPV) and cervical cancer in low and middle-income countries, stigma remains an issue. Addressing HPV and cervical cancer stigma could significantly improve health outcomes for these conditions. The objective of this study was to identify the manifestations of stigma and their potential impacts on health-seeking behavior.

methodsTwenty-six in-depth interviews were conducted with women living with HIV, HIV-negative women, community health volunteers, and health care providers in Kisumu, Kenya in 2019. The interviews were designed to draw out existing attitudes or experiences related to stigma within the community. We conducted a thematic analysis of the interviews to identify internalized, anticipated, and discriminatory attitudes.

resultsWithin internalized attitudes, a prominent observed theme was a fear of death associated with a positive HPV test. This stemmed from a lack of understanding of differences between HPV and cervical cancer and posed a significant barrier for women deciding to seek screening or to continue with treatment. Discriminatory attitudes of community members, including assumptions of promiscuity, infidelity, or HIV status, were perceived to prevent women from accessing screening and treatment opportunities. The interviews also exhibited a limited awareness of HPV in this region, which may have contributed to a lack of enacted stigma towards people living with HPV or cervical cancer.

conclusionStigma has the potential to lead to decreased screening and treatment uptake through its drivers. This includes a decreased perception of personal risk due to a lack of knowledge, which results in increased HPV-risk behaviors. Future research must focus on creating and integrating stigma-reducing interventions, primarily to encourage women to seek out primary and secondary preventative measures.

Indexed as

AlphapapillomavirusHIV InfectionsPapillomavirus InfectionsUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansKenyaPapillomaviridaePhobic DisordersCervical cancerHPVKenyaStigma

Identifiers

PMID35148778
PMCPMC8832662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.